Camber Pharmaceutical, Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Camber Pharmaceutical, Inc.

Sort by

Viewing results 1‒25 of 5491

Pfizer Inc
Pfizer plans direct-to-consumer platform for Covid and migraine treatments
US pharma group follows Eli Lilly with website for patients to obtain medication online
May 1, 2024
WPP PLC
Ogilvy forms health influencer unit to target ‘new frontier’ in marketing
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
April 23, 2024
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Covid-19 vaccines
EU delays approval of Novavax’s revised Covid jab
US biotech has been struggling to overcome fall in demand for coronavirus jabs
October 15, 2023
Special ReportThe Americas’ Fastest Growing Companies
Its blockbuster cystic fibrosis treatment costs $300,000 a year. Now Vertex wants to solve the opioid crisis
...So effective is Vertex Pharmaceuticals’ blockbuster cystic fibrosis (CF) drug, Trikafta, that studies project it could extend the lives of some young patients by up to 45 years....
April 26, 2024
Novavax Inc
Sanofi licensing deal doubles value of vaccine group Novavax
...The partnership strengthens Sanofi, one of the world’s largest vaccine makers by sales, in the post-pandemic Covid jab market, where pharmaceutical groups are increasingly focused on combined shots against...
May 10, 2024
Drug prices
Copycats take bite out of AbbVie’s best-selling Humira drug
...A Humira biosimilar from Teva Pharmaceuticals working with Alvotech earlier this year became the first drug that the US Food and Drug Administration granted interchangeable status, which lets pharmacists...
April 25, 2024
FT Live
Funding Biopharma Innovation
Strategies for investing in drug development and commercialization
Wednesday, 26 June345 Park Avenue South, New York, NY, USA
Johnson & Johnson Co Inc
Johnson & Johnson proposes $6.5bn deal to settle talc cancer lawsuits
Drugmaker could fast track subsidiary’s bankruptcy process if 75% of claimants vote in favour of new plan
May 1, 2024
Equities
Pandemic-era winners suffer $1.5tn fall in market value
...Vaccine hopes and demand for medical treatments also buoyed pharmaceutical groups such as Moderna and Pfizer in 2020, as well as lesser-known Chinese groups, including WuXi Biologics, Chongqing Zhifei Biological...
May 8, 2024
News in-depthWeight Watchers International Inc
WeightWatchers faces an era when weight loss comes in a syringe
A company launched in 1963 confronts challenge of adapting to the rise of anti-obesity injections
April 9, 2024
LexInsider trading
Insider trading ruling is a warning for executives who get creative Premium content
Admonitions about staff trading in their employer’s shares may now need to be broadened
April 24, 2024
Covid-19 vaccines
Hedge fund urges board shake-up at Novavax over struggling Covid vaccine
Shah Capital wants change in US biotech’s strategy as its shares have tumbled since their pandemic peak
April 15, 2024
Johnson & Johnson Co Inc
Johnson & Johnson buys device maker Shockwave for $13.1bn
US healthcare company is putting cash to work from spinning off its consumer health arm
April 5, 2024
News in-depthCovid-19 vaccines
Covid vaccine makers to clash in London over mRNA patent dispute
...The case is the latest in a series of intellectual property battles that companies are fighting around the world over mRNA technology, which has helped generate billions in revenues for the pharmaceuticals...
April 22, 2024
Corporate bonds
Reading small print for fun and profit
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
March 7, 2024
Mergers & Acquisitions
EU wrong to block Illumina’s $8bn takeover of Grail, says court adviser
Advocate general of bloc’s top court says decision against world’s biggest gene sequencing group should be annulled
March 21, 2024
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Behind the Money podcast17 min listen
Can WeightWatchers survive the Wegovy era?
A weight loss titan fights to stay relevant in the age of GLP-1 drugs
April 10, 2024
News in-depthDementia
Alzheimer’s drug Leqembi falls short of blockbuster status in faltering US rollout
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
April 22, 2024
Medical science
UK approves Crispr gene editing therapy in global first
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics....
November 16, 2023
BlackRock Inc
BlackRock steps up security for Larry Fink after ‘anti-woke’ backlash
...Pharmaceuticals groups Pfizer and Moderna, which have both faced criticism from fringe groups over their Covid-19 vaccines, also spent heavily on security for their CEOs last year....
April 21, 2024
LexPfizer Inc
Pfizer: pharma group needs weight loss drug to secure post-Covid future Premium content
...Despite splashing out nearly $55bn on two major acquisitions over the past two years, the pharmaceutical company is worth less than it was before the pandemic....
December 13, 2023
Pfizer Inc
Pfizer shares tumble on weak forecast for 2024 revenues
US drugmaker is trying to chart its future without blockbuster Covid-19 products
December 13, 2023
Pfizer Inc
Pfizer drops plan for twice-daily obesity pill due to side effects
...Rival pharmaceutical groups are eager to enter the market, including AstraZeneca, which recently signed a licensing deal with Chinese company Eccogene for the rights to its weight loss pill....
December 1, 2023
Coronavirus treatment
Expired Pfizer Covid antiviral drugs set to cost Europe $2.2bn, data shows
Millions of Paxlovid pills have gone unused as tight controls restrict access
January 1, 2024
Coronavirus treatment
Covid antivirals lose spark as regulatory scrutiny increases
Doubts grow over safety and effectiveness of drugs that were marketed as coronavirus treatments
October 9, 2023
Anjli Raval
Competent jerks have a shelf life in the office
...At one point pharmaceutical company Pfizer even set out a “no jerks” policy....
January 14, 2024

Previous pagePage 1 of 220Next page